OM:ELOS B

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

kr2.1b

Last Updated

2021/08/04 21:38 UTC

Data Sources

Company Financials +

Executive Summary

Elos Medtech AB (publ) develops and manufactures medical devices and components for the medical technology industry. More Details


Snowflake Analysis

Excellent balance sheet and good value.

Share Price & News

How has Elos Medtech's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ELOS B is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ELOS B's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

19.4%

ELOS B

4.3%

SE Medical Equipment

1.3%

SE Market


1 Year Return

235.1%

ELOS B

64.0%

SE Medical Equipment

45.8%

SE Market

Return vs Industry: ELOS B exceeded the Swedish Medical Equipment industry which returned 64% over the past year.

Return vs Market: ELOS B exceeded the Swedish Market which returned 45.8% over the past year.


Shareholder returns

ELOS BIndustryMarket
7 Day19.4%4.3%1.3%
30 Day20.6%15.8%7.0%
90 Day51.3%23.6%9.6%
1 Year238.0%235.1%65.9%64.0%51.0%45.8%
3 Year274.9%267.5%122.6%114.4%79.3%61.9%
5 Year155.3%124.3%139.8%101.6%115.2%73.6%

Long-Term Price Volatility Vs. Market

How volatile is Elos Medtech's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Elos Medtech undervalued compared to its fair value and its price relative to the market?

49.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ELOS B (SEK258) is trading below our estimate of fair value (SEK507.44)

Significantly Below Fair Value: ELOS B is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ELOS B is good value based on its PE Ratio (33.5x) compared to the Swedish Medical Equipment industry average (42x).

PE vs Market: ELOS B is poor value based on its PE Ratio (33.5x) compared to the Swedish market (23x).


Price to Earnings Growth Ratio

PEG Ratio: ELOS B is poor value based on its PEG Ratio (2.3x)


Price to Book Ratio

PB vs Industry: ELOS B is good value based on its PB Ratio (3.6x) compared to the SE Medical Equipment industry average (5.8x).


Future Growth

How is Elos Medtech forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

14.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELOS B's forecast earnings growth (14.4% per year) is above the savings rate (0.3%).

Earnings vs Market: ELOS B's earnings (14.4% per year) are forecast to grow faster than the Swedish market (4.3% per year).

High Growth Earnings: ELOS B's earnings are forecast to grow, but not significantly.

Revenue vs Market: ELOS B's revenue (13.3% per year) is forecast to grow faster than the Swedish market (2.9% per year).

High Growth Revenue: ELOS B's revenue (13.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ELOS B's Return on Equity is forecast to be low in 3 years time (12.9%).


Past Performance

How has Elos Medtech performed over the past 5 years?

16.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ELOS B has a large one-off loss of SEK40.0M impacting its June 30 2021 financial results.

Growing Profit Margin: ELOS B's current net profit margins (9.5%) are higher than last year (4.9%).


Past Earnings Growth Analysis

Earnings Trend: ELOS B's earnings have grown by 16.6% per year over the past 5 years.

Accelerating Growth: ELOS B's earnings growth over the past year (115%) exceeds its 5-year average (16.6% per year).

Earnings vs Industry: ELOS B earnings growth over the past year (115%) exceeded the Medical Equipment industry 36.9%.


Return on Equity

High ROE: ELOS B's Return on Equity (10.7%) is considered low.


Financial Health

How is Elos Medtech's financial position?


Financial Position Analysis

Short Term Liabilities: ELOS B's short term assets (SEK372.4M) exceed its short term liabilities (SEK178.6M).

Long Term Liabilities: ELOS B's short term assets (SEK372.4M) exceed its long term liabilities (SEK316.6M).


Debt to Equity History and Analysis

Debt Level: ELOS B's debt to equity ratio (42.1%) is considered high.

Reducing Debt: ELOS B's debt to equity ratio has reduced from 96% to 42.1% over the past 5 years.

Debt Coverage: ELOS B's debt is well covered by operating cash flow (51.1%).

Interest Coverage: ELOS B's interest payments on its debt are well covered by EBIT (23.8x coverage).


Balance Sheet


Dividend

What is Elos Medtech current dividend yield, its reliability and sustainability?

0.58%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: ELOS B's dividend (0.58%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (0.92%).

High Dividend: ELOS B's dividend (0.58%) is low compared to the top 25% of dividend payers in the Swedish market (3.4%).


Stability and Growth of Payments

Stable Dividend: ELOS B's dividend payments have been volatile in the past 10 years.

Growing Dividend: ELOS B's dividend payments have not increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (19.5%), ELOS B's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: ELOS B's dividends in 3 years are forecast to be thoroughly covered by earnings (13.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.4yrs

Average management tenure


CEO

Jan Wahlström (54 yo)

5.08yrs

Tenure

Mr. Jan Wahlström has been the Chief Executive Officer and President of Elos Medtech AB since July 1, 2016. Mr. Wahlström joined Elos Medtech from his role as President of Larodan AB. Mr. Wahlström served ...


Leadership Team

Experienced Management: ELOS B's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

Experienced Board: ELOS B's board of directors are considered experienced (4.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ELOS B insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Elos Medtech AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elos Medtech AB (publ)
  • Ticker: ELOS B
  • Exchange: OM
  • Founded: 1923
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr2.082b
  • Shares outstanding: 8.07m
  • Website: https://www.elosmedtech.com

Number of Employees


Location

  • Elos Medtech AB (publ)
  • Torsgatan 5B
  • Gothenburg
  • Västra Götaland County
  • 411 04
  • Sweden

Listings


Biography

Elos Medtech AB (publ) develops and manufactures medical devices and components for the medical technology industry. The company operates in three segments: Dental, Orthopedics, and Life Science. The Denta...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/08/04 21:38
End of Day Share Price2021/08/04 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.